$SIBN News

SI-BONE (SIBN) Q2 2026 Earnings Call Transcript

Does Si-Bone (SIBN) Have the Potential to Rally 38.58% as Wall Street Analysts Expect?

UBS Maintains Buy on SI-BONE, Raises Price Target to $25

Truist Securities Reiterates Buy on SI-BONE, Raises Price Target to $23

TD Cowen Maintains Buy on SI-BONE, Raises Price Target to $20

SI-BONE, Inc. Q2 2026 Earnings Call Summary

SI-BONE, Inc. (SIBN) Q2 2026 Earnings Call Transcript

SI-BONE Inc (SIBN) (Q2 2026) Earnings Call Highlights: Strong Revenue Growth and Raised ...

SI-BONE (NASDAQ:SIBN) Beats EPS and Raises Guidance, But Shares Slip

Si-Bone (SIBN) Reports Q2 Loss, Tops Revenue Estimates

SiBone Q2 Earnings Call Highlights

SI-BONE, Inc. Reports Financial Results for the Second Quarter 2026 and Raises 2026 Guidance

SI-BONE Raises FY2026 Sales Guidance from $230.000M-$233.000M to $231.000M-$233.000M vs $231.775M Est

SI-BONE Q2 EPS $(0.09) Beats $(0.15) Estimate, Sales $56.010M Beat $55.335M Estimate

UBS Initiates Coverage On SI-BONE with Buy Rating, Announces Price Target of $24

SI-BONE To Report Second Quarter 2026 Financial Results on August 3, 2026

Truist Securities Maintains Buy on SI-BONE, Raises Price Target to $21

SI-BONE To Present at Truist Securities 2026 MedTech Conference on June 16, 2026

Bears are Losing Control Over Si-Bone (SIBN), Here's Why It's a 'Buy' Now

Wall Street Analysts Predict a 71.13% Upside in Si-Bone (SIBN): Here's What You Should Know